Skip to main content
lexblog.com/lib/9CCFB17Nviewrecordjson
{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "Of Drugs and DTC Platforms: American Consumerism, TrumpRx, Telehealth, and the Specter of Congressional Intervention",
    "url": "https://www.lexblog.com/2026/02/03/of-drugs-and-dtc-platforms-american-consumerism-trumprx-telehealth-and-the-specter-of-congressional-intervention/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-9CCFB17N",
        "url": "https://www.lexblog.com/lib/9CCFB17N/"
    },
    "datePublished": "2026-02-03T17:11:13-05:00",
    "dateModified": "2026-02-04T15:05:05-05:00",
    "author": {
        "@type": "Person",
        "name": "Dominick DiSabatino, Scott Liebman, Julian Klein"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Sheppard, Mullin, Richter & Hampton LLP"
    },
    "organizationScope": "at-publication",
    "about": "Health Care and Life Sciences",
    "sourceUrl": "https://www.fdalawblog.com/?p=2348",
    "sourceStability": "may-move"
}